share_log

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

为什么MIRA Pharmaceuticals股票交易价格上涨约45％； 以下是20支股票的盘前动态
Benzinga ·  08/26 05:58

Shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) rose sharply in today's pre-market trading after company announced it achieved 100% reversal of neuropathic pain with oral Ketamin-2 in a rat study.

MIRA制药股票（纳斯达克股票代码：MIRA）在今天的美股盘前交易中大幅上涨，因公司宣布其口服氯胺酮-2在大鼠研究中实现神经病理性疼痛100%逆转。

MIRA Pharmaceuticals shares jumped 44.8% to $2.68 in the pre-market trading.

生物医药股票在美股盘前交投中上涨44.8%，报2.68美元。

Here are some other stocks moving in pre-market trading.

以下是其他在美股盘前交易中受到影响的股票。

Gainers

涨幅

  • MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) gained 135.5% to $5.84 in pre-market trading. MEDIROM MOTHER Labs partnered with NFES Technologies in capital and business alliance.
  • Prestige Wealth Inc. (NASDAQ:PWM) rose 57% to $1.17 in today's pre-market trading after the company announced that it entered into a definitive acquisition agreement to purchase all shares of SPW Global.
  • Top KingWin Ltd (NASDAQ:TCJH) gained 45.6% to $0.33 in pre-market trading after gaining 13% on Friday.
  • Tevogen Bio Holdings Inc (NASDAQ:TVGN) gained 32.8% to $0.77 in pre-market trading. Tevogen Bio, last week, secured $6 million Series C Preferred stock investment with The Patel Family, LLP.
  • Perfect Moment Ltd. (NASDAQ:PMNT) gained 28.8% to $1.34 in pre-market trading after declining 7% on Friday.
  • Scisparc Ltd (NASDAQ:SPRC) gained 19.1% to $0.44 in pre-market trading after the company submitted an Investigational New Drug (IND) application to the FDA for SCI-110.
  • Santech Holdings Ltd – ADR (NASDAQ:STEC) gained 8.3% to $0.42 in pre-market trading after announcing a $5 million share repurchase program.
  • Galapagos NV – ADR (NASDAQ:GLPG) climbed 8.3% to $28.07 in pre-market trading. On Friday, Galapagos announced the FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma.
  • LandBridge Co LLC (NYSE:LB) gained 7% to $44.99 in the pre-market trading session after gaining 5% on Friday.
  • MEDIROm Healthcare Technologies Inc.（纳斯达克股票代码：MRM）在盘前交投中上涨135.5%，报5.84美元。MEDIROm MOTHER Labs与NFES Technologies在资本和业务联盟方面合作。
  • Prestige Wealth Inc.（纳斯达克股票代码：PWM）在今日盘前交投中上涨57%，报1.17美元。该公司宣布达成一份明确的收购协议，将收购SPW Global的所有股份。
  • Top KingWin Ltd（纳斯达克股票代码：TCJH）在盘前交投中上涨45.6%，报0.33美元，此前在周五上涨了13%。
  • Tevogen Bio Holdings Inc（纳斯达克股票代码：TVGN）在盘前交投中上涨32.8%，报0.77美元。Tevogen Bio上周与The Patel Family, LLP达成了一项600万美元C轮优先股投资协议。
  • 美股盘前交易中，Perfect Moment Ltd. (NASDAQ:PMNT)涨28.8%，至1.34美元，在周五下跌7%后。
  • 美股盘前交易中，Scisparc Ltd (NASDAQ:SPRC)涨19.1%，至0.44美元，该公司已向美国FDA提交了SCI-110的新药申请。
  • 美股盘前交易中，Santech Holdings Ltd – ADR (NASDAQ:STEC)涨8.3%，至0.42美元，宣布了一项500万美元的股票回购计划。
  • 美股盘前交易中，Galapagos NV – ADR (NASDAQ:GLPG)上涨了8.3%，至28.07美元。上周，Galapagos宣布FDA批准了ATLANTA-1研究的CD19 CAR-t,GLPG5101在复发/难治性非霍奇金淋巴瘤的新药申请。
  • 纽交所(NYSE:LB)美股盘前交易中上涨了7%，至44.99美元，在周五上涨了5%。

Losers

跌幅

  • Talis Biomedical Corp (NASDAQ:TLIS) declined 14.8% to $3.85 in pre-market trading. The Nasdaq notified Talis Biomedical that Nasdaq believes the company is "public shell," & continued listing of its common stock is no longer warranted.
  • SRIVARU Holding Limited (NASDAQ:SVMH) shares declined 14.5% to $0.14 in pre-market trading. SRIVARU Holding recently announced the formal launch of the PRANA 2.0 electric motorcycle at a major event in Chennai, India. Also, the company said it aims to increase production capacity to nearly 10,000 units per month by the end of 2024
  • Draganfly Inc. (NASDAQ:DPRO) fell 14.5% to $0.12 in pre-market trading after gaining 6% on Friday.
  • ELEVAI Labs Inc (NASDAQ:ELAB) shares fell 13.5% to $0.26 in pre-market trading after gaining around 33% on Friday.
  • OKYO Pharma Ltd (NASDAQ:OKYO) fell 12.3% to $0.91 in pre-market trading.
  • Tungray Technologies Inc (NASDAQ:TRSG) shares declined 11.9% to $2.59 in pre-market trading.
  • Avenue Therapeutics Inc (NASDAQ:ATXI) fell 11.2% to $2.62 in today's pre-market trading.
  • Renalytix PLC (NASDAQ:RNLX) shares fell 10.1% to $0.29 in pre-market trading after declining 5% on Friday.
  • SM Energy Co (NYSE:SM) shares fell 7.4% to $42.42 in pre-market trading. SM Energy recently reported better-than-expected second-quarter financial results.
  • Xiao-I Corp (NASDAQ:AIXI) shares dipped 6.7% to $4.02 in pre-market trading after surging 20% on Friday.
  • 美股盘前交易中，Talis Biomedical Corp (NASDAQ:TLIS)下跌了14.8%，至3.85美元。纳斯达克通知Talis Biomedical，纳斯达克认为该公司是“空壳公司”，继续上市其普通股不再合适。
  • 美股盘前交易中，SRIVARU Holding Limited (NASDAQ:SVMH)股价下跌14.5%，至0.14美元。SRIVARU Holding最近在印度金奈市的一次重大活动上正式推出PRANA 2.0电动摩托车。此外，公司表示，计划到2024年底将产能增加至近1万台每月。
  • Draganfly公司（纳斯达克：DPRO）在上周五上涨6%后，在美股盘前交易中下跌14.5%，跌至0.12美元。
  • ELEVAI Labs公司（纳斯达克：ELAB）股价在上周五上涨约33%后，在美股盘前交易中下跌13.5%，跌至0.26美元。
  • OKYO Pharma Ltd公司（纳斯达克：OKYO）股价在美股盘前交易中下跌12.3%，跌至0.91美元。
  • Tungray Technologies公司（纳斯达克：TRSG）股价在美股盘前交易中下跌11.9%，跌至2.59美元。
  • Avenue Therapeutics公司（纳斯达克：ATXI）在今天的美股盘前交易中下跌11.2%，跌至2.62美元。
  • Renalytix生物医药公司（纳斯达克：RNLX）股价在上周五下跌5%后，在美股盘前交易中下跌10.1%，跌至0.29美元。
  • Sm Energy公司（纽交所：SM）股价在美股盘前交易中下跌7.4%，跌至42.42美元。Sm Energy最近公布了超出预期的第二季度财务业绩。
  • Xiao-I公司（纳斯达克：AIXI）股价在上周五飙涨20%后，在美股盘前交易中下跌6.7%，跌至4.02美元。

Now Read This:

现在阅读这个：

  • Jim Cramer Praises L3Harris Technologies, Says Intel Is 'Getting Whacked' By AMD: 'I Much Prefer...'
  • 吉姆·克雷默赞扬L3Harris Technologies，并表示英特尔（Intel）正受到AMD的打击：'我更喜欢……'
声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发